Health Bulletin 6/October/2022 - Video

Here are the top health news for the day:

WHO says probing four Indian cough syrups after 66 children die in Gambia

After the World Health Organization (WHO) issued an alert on four India-made cough and cold syrups used for pediatric groups, the Central Drugs Standard Control Organization (CDSCO) has taken up an urgent investigation in this regard.

"Urgent investigation in the matter has been already taken up by CDSCO with the State Regulatory Authorities immediately after receiving communication from WHO based on the available information. While all required steps will be taken in the matter, as a robust National Regulatory Authority, WHO has been requested to share at the earliest with CDSCO the report on the establishment of causal relation to death with the medical products in question, photographs of Labels/ products etc. which is awaited," Sources told ANI.

For more details, check out the link given below:

Indian Cough Syrups Linked To 66 Children Deaths In Gambia, WHO Alerts, CDSCO Begins Investigation

Drug safety alert: IPC flags adverse reactions linked to rheumatoid arthritis drug piroxicam

The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of September ,has revealed that Piroxicam, a non-steroidal anti-inflammatory agent (NSAID) which is used to treat the symptoms of osteoarthritis and rheumatoid arthritis, is linked with Adverse Drug Reactions (ADRs) named Fixed Drug Eruption.

This came after preliminary analysis of Adverse Drug Reactions (ADRs) from the Pharmacovigilance Programme of India (PvPI) database.

Piroxicam is in a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). Piroxicam works by reducing hormones that cause inflammation and pain in the body. Piroxicam is used to reduce the pain, inflammation, and stiffness caused by rheumatoid arthritis and osteoarthritis.

For more details, check out the link given below:

Drug Safety Alert: IPC Flags Adverse Reactions Linked To Rheumatoid Arthritis Drug Piroxicam

Eight new medical colleges in Telangana to commence admission from this year, 2200 additional MBBS seats available for aspirants

In a major boost to medical education in Telangana, the State Government has announced that admission in eight new medical colleges in the State will commence from this year.

Along with 1067 MBBS seats through 85 percent reservation in B Category, Telangana will offer more than 2200 additional MBBS seats to the aspirants this year, adds Telangana Today.

The announcement in this regard has come from the State Government on Monday, on the occasion of Durga Ashtami and Saddula Bathukamma.

For more details, check out the link given below:

Eight New Medical Colleges In Telangana To Commence Admission From This Year, 2200 Additional MBBS Seats Available For Aspirants